EUROPEAN JOURNAL OF HAEMATOLOGY, vol.101, no.4, pp.556-565, 2018 (SCI-Expanded)
Article / Article
EUROPEAN JOURNAL OF HAEMATOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Istanbul University Affiliated:
Objective: The efficacy and safety of bortezomib-based therapy for relapsed/refractory multiple myeloma (RRMM) in clinical trials may differ from the oncology practice experience. The electronic VELCADE (R) OBservational Study was designed to prospectively evaluate bortezomib for multiple myeloma (MM) in real-world medical practice.